Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,867 total articles

Alliance Entertainment Plays Key Role in Historic Record Store Day

Alliance Entertainment Plays Key Role in Historic Record Store Day

Alliance Entertainment played a pivotal role in the historic 2026 Record Store Day by shipping over 700,000 units to more than 1,500 independent music retailers across the U.S., representing an 8% increase from the previous year and supporting the largest release slate to date. This underscores the company's operational capabilities and strong posi…

Aether Holdings Launches OpenTicker, an Open-Source Framework for Building and Running Automated Trading Strategies

Aether Holdings Launches OpenTicker, an Open-Source Framework for Building and Running Automated Trading Strategies

Aether Holdings, Inc., a Nasdaq-listed financial technology company, launched OpenTicker, an open-source framework built to help traders and developers create, manage, and run automated trading workflows with enhanced transparency and configurability. The platform integrates various market data and execution services with recovery tools and support…

HomeTrust Bancshares, Inc. Announces Financial Results for the First Quarter of the Year Ending December 31, 2026 and an Increase in the Quarterly Dividend

HomeTrust Bancshares, Inc. Announces Financial Results for the First Quarter of the Year Ending December 31, 2026 and an Increase in the Quarterly Dividend

HomeTrust Bancshares, Inc. reported a 4.0% increase in net income for Q1 2026 compared to the previous quarter, driven by improved net interest margin, a significant reduction in credit loss provision, and stronger noninterest income. The company also increased its quarterly dividend by 15.4%, marking its eighth dividend increase since inception. F…

Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026

Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026

Moleculin Biotech announced that their lead drug candidate, Annamycin, demonstrated a more than 60% extension in survival in preclinical metastatic pancreatic cancer models. The non-cardiotoxic anthracycline showed significant tumor reduction, superior tumor tissue accumulation compared to doxorubicin, and immune activation within the tumor microen…

Teads and LG Ad Solutions Expand Global Partnership to Bring High-Attention CTV Ads to the ‘Omnichannel Living Room’

Teads and LG Ad Solutions Expand Global Partnership to Bring High-Attention CTV Ads to the ‘Omnichannel Living Room’

Teads Holding Co. renewed and expanded its exclusive partnership with LG Ad Solutions to deliver high-attention Connected TV (CTV) advertising in new European and Asia-Pacific markets. The collaboration allows advertisers to access LG Smart TV inventory through Teads' omnichannel platform, enhancing reach to premium audiences with advanced measurem…

StepStone Group Closes Second Credit Opportunities Fund

StepStone Group Closes Second Credit Opportunities Fund

StepStone Group Inc. successfully closed its second Credit Opportunities Fund (SCOF II) with over $1.58 billion raised, more than double its initial $750 million target. The fund focuses on private credit investments primarily through secondaries and co-investments, targeting attractive opportunities across various sectors and credit asset classes.…

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

Ardelyx, Inc. announced acceptance of an abstract on irritable bowel syndrome with constipation (IBS-C) treatment patterns for presentation at Digestive Disease Week 2026. The presentation explores patient characteristics linked to treatment changes and their impact on gastrointestinal healthcare resource use. Ardelyx will also sponsor a clinical d…

Belite Bio to Participate in Four Upcoming Investor Conferences

Belite Bio to Participate in Four Upcoming Investor Conferences

Belite Bio, a clinical-stage biopharmaceutical company focused on treatments for degenerative retinal diseases, announced participation in four upcoming investor conferences between April and May 2026. The company will provide presentations and fireside chats detailing progress and prospects for its lead drug candidate, tinlarebant, which is curren…

Cass Information Systems reports First Quarter 2026 Results

Cass Information Systems reports First Quarter 2026 Results

Cass Information Systems, Inc. reported a strong first quarter for 2026, delivering 23.7% growth in adjusted net income from continuing operations compared to the prior year. The company achieved an increase in net interest margin to 3.95%, expansion in facility dollar volumes, and maintained flat personnel expenses through automation and expense c…

VisionWave Holdings, Inc. (Nasdaq: VWAV) Corporate Update

VisionWave Holdings, Inc. (Nasdaq: VWAV) Corporate Update

VisionWave Holdings, Inc. (Nasdaq: VWAV) provided a corporate update detailing significant progress since March 30, 2026, including acquiring AI video intelligence IP (xClibre), signing a non-binding term sheet to acquire a majority stake in Foresight Autonomous Holdings (FRSX), receiving its first commercial order from a Latin American public safe…

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

MBX Biosciences, a clinical-stage biopharmaceutical company specializing in peptide therapies for endocrine and metabolic disorders, announced an in-person and virtual event on May 11, 2026, to update investors and stakeholders on its growing obesity product pipeline. The event will feature expert presentations on the evolving obesity treatment lan…

Teads to Release First Quarter 2026 Financial Results on May 7, 2026

Teads to Release First Quarter 2026 Financial Results on May 7, 2026

Teads Holding Co., a leading omnichannel advertising platform, will release its first quarter 2026 financial results before market open on May 7, 2026. The company will hold a conference call the same day to discuss the results and business outlook. Teads leverages AI technology to deliver advertising outcomes across screens and partners with thous…

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

Reviva Pharmaceuticals announced that its CEO, Laxminarayan Bhat, will participate in an A.G.P.-hosted fireside chat to discuss the clinical developments and upcoming milestones for brilaroxazine, a promising drug candidate targeting schizophrenia and other neuropsychiatric and inflammatory diseases. Positive Phase 3 data and orphan drug designatio…

High Roller Technologies Signs Definitive Agreement with Leverage Game Media to Support U.S. Prediction Markets Launch

High Roller Technologies Signs Definitive Agreement with Leverage Game Media to Support U.S. Prediction Markets Launch

High Roller Technologies, Inc. has entered a strategic marketing partnership with Leverage Game Media to support the launch and growth of its regulated event-based prediction markets product in the U.S. The partnership aims to leverage Leverage's extensive social media platforms and data-driven marketing to accelerate user acquisition and brand awa…

Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States

Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States

Nano-X Imaging Ltd. (Nasdaq: NNOX) announced a new distribution agreement with Radiology Oncology Systems (ROS) to expand the commercial deployment of its Nanox.ARC multi-source digital tomosynthesis imaging systems in the United States. With FDA clearance and a cost-effective, lower-radiation 3D imaging solution, the collaboration aims to broaden …